Abbott Recalls HeartMate Touch System Over Risk of Unintended Pump Stops
Abbott is recalling its HeartMate Touch communication system, which monitors patients with an implantable HeartMate 3 left ventricular assist device.
Read MoreAbbott is recalling its HeartMate Touch communication system, which monitors patients with an implantable HeartMate 3 left ventricular assist device.
Read MoreThe vest has 256 sensors rather than the 12 used in a standard electrocardiogram and can provide detailed electrical mapping of the heart in just five minutes.
Read MoreThe non-invasive wearable device captures cardiopulmonary measurements for chronic disease management such as heart failure.
Read MoreThe FDA approves Boston Scientific Corporation’s AGENT Drug-Coated Balloon for treating coronary in-stent restenosis, marking the first drug-coated coronary balloon approval in the United States.
Read MoreDaily use was associated with a 25% increased likelihood of heart attack and a 42% increased likelihood of stroke.
Read More